C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/4465 (2006.01) A61K 31/4545 (2006.01) A61P 25/00 (2006.01) C07D 401/14 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2659192
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
L'invention concerne des composés de formule I, y compris leurs sels pharmaceutiquement acceptables, leurs compositions pharmaceutiques et leur utilisation pour le traitement de troubles du système nerveux central.
Bronson Joanne J.
Gillman Kevin W.
Parker Michael F.
Silva Mark V.
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Substituted heterocyclic ethers and their use in cns disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic ethers and their use in cns disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic ethers and their use in cns disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2069565